Literature DB >> 29718110

Tracking the Epigenetic Clock Across the Human Life Course: A Meta-analysis of Longitudinal Cohort Data.

Riccardo E Marioni1,2, Matthew Suderman3, Brian H Chen4, Steve Horvath5,6, Stefania Bandinelli7, Tiffany Morris8, Stephan Beck8, Luigi Ferrucci4, Nancy L Pedersen9, Caroline L Relton3, Ian J Deary1,10, Sara Hägg9.   

Abstract

Background: Epigenetic clocks based on DNA methylation yield high correlations with chronological age in cross-sectional data. Due to a paucity of longitudinal data, it is not known how Δage (epigenetic age - chronological age) changes over time or if it remains constant from childhood to old age. Here, we investigate this using longitudinal DNA methylation data from five datasets, covering most of the human life course.
Methods: Two measures of the epigenetic clock (Hannum and Horvath) are used to calculate Δage in the following cohorts: Avon Longitudinal Study of Parents and Children (ALSPAC) offspring (n = 986, total age-range 7-19 years, 2 waves), ALSPAC mothers (n = 982, 16-60 years, 2 waves), InCHIANTI (n = 460, 21-100 years, 2 waves), SATSA (n = 373, 48-99 years, 5 waves), Lothian Birth Cohort 1936 (n = 1,054, 70-76 years, 3 waves), and Lothian Birth Cohort 1921 (n = 476, 79-90 years, 3 waves). Linear mixed models were used to track longitudinal change in Δage within each cohort.
Results: For both epigenetic age measures, Δage showed a declining trend in almost all of the cohorts. The correlation between Δage across waves ranged from 0.22 to 0.82 for Horvath and 0.25 to 0.71 for Hannum, with stronger associations in samples collected closer in time. Conclusions: Epigenetic age increases at a slower rate than chronological age across the life course, especially in the oldest population. Some of the effect is likely driven by survival bias, where healthy individuals are those maintained within a longitudinal study, although other factors like the age distribution of the underlying training population may also have influenced this trend.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29718110      PMCID: PMC6298183          DOI: 10.1093/gerona/gly060

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


A number of studies have demonstrated age-related methylation differences at specific CpG sites. Indeed, linear combinations of CpG methylation beta values—labelled epigenetic clocks—correlate highly with chronological age (Pearson r > 0.90) (1,2). For a given chronological age, older epigenetic age is presumed to indicate poorer health, and has been associated with increased mortality risk (3) and many age-related morbidities (4,5). Because published epigenetic clocks were derived from cross-sectional data, it is unknown whether individual differences between epigenetic age and chronological age (Δage) are (i) set at birth and continue unchanged over the life course, (ii) changing gradually across the life course, or (iii) changing more notably during specific periods of life, for example, adolescence and old age. Such questions can be tested using cross-sectional data, although repeated measurements at multiple times hold clear advantages for inference, especially because they are not biased by selective survival. In this study, we use longitudinal methylation data from five population-based cohorts, spanning the life course from early childhood to death.

Methods

Longitudinal DNA methylation data were collected in five cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC), Invecchiare in Chianti (InCHIANTI), the Swedish Adoption/Twin Study of Aging (SATSA), the Lothian Birth Cohort 1936 (LBC1936), and the Lothian Birth Cohort 1921 (LBC1921). ALSPAC is a “transgenerational prospective observational study investigating influences on health and development across the life course” (6,7). Participants comprise a cohort of offspring born to pregnant women recruited in 1991–1992 in Bristol, UK. Participants have been followed through a series of ongoing data collection waves involving questionnaires and clinical assessments. Please note that the study website contains details of all the data that is available through a fully searchable data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/). DNA methylation was measured in the peripheral blood of the offspring at ages 7 and 15–17 (986 individuals corresponding to 1,901 samples) and of their mothers during pregnancy and approximately 18 years later (982 individuals corresponding to 1,816 samples). The resulting profiles form part of the Accessible Resource for Integrated Epigenomics Studies (ARIES) dataset (8). Data are available by request from the Avon Longitudinal Study of Parents and Children Executive Committee (http://www.bristol.ac.uk/alspac/researchers/access/). The InCHIANTI study is a population-based prospective cohort study of residents aged 20 or older from two areas in the Chianti region of Tuscany, Italy. Sampling and data collection procedures have been described elsewhere (9). Briefly, 1,326 participants donated a blood sample at baseline (1998–2000), of which 784 also donated a blood sample at the 9-year follow-up (2007–2009). DNA methylation was assayed in participants with sufficient DNA at both baseline and 9-year visits (n = 499). After samples and data quality checks, DNA methylation data at baseline and follow-up were available in 460 individuals. The SATSA study is a longitudinal prospective cohort study of adult Swedish twins (10,11). It was started in 1984 and has been ongoing until 2014. There are up to 10 waves of in-person testing available with questionnaire data on health and life-style choices, cognitive testing, physical performance measures, anthropometrics, and blood draws. DNA methylation was assessed repeatedly up to five times in 373 individuals corresponding to 938 samples. The age ranges in the methylation SATSA samples spanned from 48 to 89 years at baseline (1992) and 63 to 99 years at the last follow-up (2012). LBC1921 and LBC1936 are birth cohorts containing Scottish participants born in 1921 and 1936, most of whom participated in the Scottish Mental Surveys of 1932 and 1947, when nearly all 11-year old Scottish children completed a cognitive test (12,13). Longitudinal follow up of those living in the Lothian area began in 2000 for those born in 1921 and in 2006 for those born in 1936. Blood-based DNA methylation data were available at three times in both cohorts—mean ages 70, 73, and 76 years in LBC1936 (1,054 individuals corresponding to 2,338 samples), and mean ages 79, 87, and 90 in LBC1921 (476 individuals corresponding to 703 samples).

Ethics

In ALSPAC, informed written consent was obtained from parents of participants after receiving a complete description of the study at the time of enrolment into the ALSPAC project, with the option for them or their children to withdraw at any time. Ethical approval for the ALSPAC study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. InCHIANTI participants provided written informed consent to participate in this study. The study complied with the Declaration of Helsinki. The Italian National Institute of Research and Care on Aging Institutional Review Board approved the study protocol and study participants provided informed consent. Participants in SATSA provided informed consents at each testing occasion. The longitudinal collection and analyses of data have been approved at several occasions by the Research Ethics Committee at Karolinska Institutet with Dnrs 84:61, and 98–319, and by the Regional Ethics Board in Stockholm with Dnrs 2007/151-31/4, 2010/657-31/3, and 2015/1729–31/5. Following written informed consent, venesected whole blood was collected for DNA extraction in both LBC1921 and LBC1936. Ethics permission for the LBC1921 was obtained from the Lothian Research Ethics Committee (Wave 1: LREC/1998/4/183). Ethics permission for the LBC1936 was obtained from the Multi-Centre Research Ethics Committee for Scotland (Wave 1: MREC/01/0/56), the Lothian Research Ethics Committee (Wave 1: LREC/2003/2/29), and the Scotland A Research Ethics Committee (Waves 2 and 3: 07/MRE00/58).

DNA Methylation and Epigenetic Clock Measurements

Blood-based Illumina 450k methylation data were obtained separately in each cohort. Cohort specific quality control details have been reported previously (14–17). Epigenetic age was calculated by multiplying beta values by the regression weights from Horvath (2) and Hannum et al. (1) to create the respective clocks. The Hannum clock was derived using DNA methylation from blood in a single cohort of 656 individuals; the Horvath clock was derived using DNA methylation from 51 tissue types across 8,000 individuals from multiple studies. The Hannum clock was developed from the Illumina 450K array, while the Horvath clock was restricted to approximately 21,000 probes common to both the Illumina 27K and 450K arrays. Further, the Hannum clock is moderately correlated with proportions of certain blood cells, while the Horvath clock is relatively uncorrelated with blood cell counts to date. Delta age was defined as a simple subtraction of chronological age from epigenetic age using both versions of the clock. Cell count predictions were estimated from DNA methylation data using the Houseman method in all cohorts (18).

Statistical Analysis

Linear mixed models were used to assess longitudinal change in Δage separately in each cohort. Δage was modelled as the outcome, with chronological age as the time-scale and predictor of interest. All models controlled for sex and a random effect intercept term. The SATSA study further adjusted for the twin structure in the data by allowing for additional random effects within twin pairs. Analyses were conducted in R using the lme4 and lmerTest packages. Pearson correlations were calculated for Horvath and Hannum Δage between waves for all pair-wise combinations in each cohort. Sensitivity analyses were carried out using only individuals present in at least three waves and using cell count prediction adjustments for the Hannum clock.

Results

The total number of individuals participating in this study was 4,075 with a total of 8,616 samples. Summary statistics of chronologic and epigenetic age at each study wave of the participating cohorts are presented in Table 1. Individuals from the different cohorts represent most of the human life course, from young children to the oldest old, although the majority of the samples were drawn in later life. All cohorts with the exception of the ALSPAC mothers had an even distribution of men and women. The number of follow-up occasions in the cohorts varied from two to five, with different time intervals in between the measurements.
Table 1.

Characteristics of Longitudinal Methylation Cohorts

CohortWaveYearParticipants (N)Women (%)Age mean ± SDHorvath Age Mean ± SDHannum Age Mean ± SD
SATSA11992–19942126068.3 ± 9.160.3 ± 9.965.3 ± 9.3
21999–20012276371.0 ± 10.163.2 ± 8.866.9 ± 8.9
32002–20041785472.1 ± 9.264.0 ± 8.868.3 ± 9.1
42008–20101726175.9 ± 8.267.3 ± 9.271.0 ± 7.8
52010–20121496677.8 ± 8.267.3 ± 9.171.4 ± 7.8
LBC193612004–20079204969.6 ± 0.866.0 ± 6.571.3 ± 5.8
22007–20108004872.5 ± 0.769.3 ± 6.672.9 ± 5.7
32011–20136184876.3 ± 0.772.6 ± 6.477.6 ± 5.6
LBC192111999–20014466079.1 ± 0.673.7 ± 7.080.3 ± 6.2
22007–20081755486.7 ± 0.477.6 ± 6.081.6 ± 6.2
32011–2012825490.1 ± 0.979.3 ± 6.184.8 ± 5.8
ALSPAC11998–2000948507.5 ± 0.158.3 ± 2.49.2 ± 4.6
Children22006–20109535217.1 ± 1.017.2 ± 4.320.4 ± 4.9
ALSPAC11991–199292410029.1 ± 4.430.2 ± 6.734.9 ± 5.6
Mothers22008–201189210047.4 ± 4.545.1 ± 6.547.1 ± 6.2
InCHIANTI11998–20004605462.2 ± 16.161.6 ± 13.367.6 ± 16.0
22007–20094605471.4 ± 16.268.7 ± 13.175.2 ± 15.9
Characteristics of Longitudinal Methylation Cohorts The fitted mean trajectories of Δage over time for each cohort are presented together in Figure 1. As the Hannum clock was not trained on children, the ALSPAC children were excluded from the Hannum plot. Participant level trajectories for each cohort for the Horvath- and Hannum epigenetic clock measures, as well as respective Δage, are shown in Supplementary Figure 1A–D. Judging from the trajectories and the mixed model output (Supplementary Table 1), Δage declines during adulthood (βHorvath ranged from −0.18 to −0.40, all P < 2 × 10−16; βHannum ranged from −0.09 to −0.62, all P < 4 × 10−16), and also during childhood, although to a smaller degree (βHorvath = −0.07, P = 8 × 10−7). In other words, over time, the DNA methylation-based biological clock increases at a slower rate than chronological age. The only exception to this trend was the Lothian Birth Cohort 1936, where Δage remained constant over a 6-year interval between ages 70 and 76 years (βHorvath = −0.01, P = 0.81; βHannum = −0.04, p = .16). Sensitivity analyses keeping only individuals with at least three waves of measurements (n = 183 in SATSA, 487 in LBC1936, and 66 in LBC1921) did not change the results (Supplementary Table 2). Likewise, adjustments for predicted cell counts for the Hannum epigenetic clock measurements did not change the age estimates remarkably (Supplementary Table 3).
Figure 1.

Mean linear longitudinal trajectories of epigenetic Δage. For each data set, mixed models were applied and predicted values, derived from the model intercept and fixed effect estimates for age, were plotted to illustrate the Δage trajectories across the life span. The x-axis represents the age where the cohort specific trajectory is plotted corresponding to the age span covered in that cohort. The y-axis shows the Δage.

Mean linear longitudinal trajectories of epigenetic Δage. For each data set, mixed models were applied and predicted values, derived from the model intercept and fixed effect estimates for age, were plotted to illustrate the Δage trajectories across the life span. The x-axis represents the age where the cohort specific trajectory is plotted corresponding to the age span covered in that cohort. The y-axis shows the Δage. The correlation between Δage across waves is presented by cohort in Table 2, and ranged from 0.22 to 0.82 for Horvath and 0.25 to 0.71 for Hannum. The association of between-wave correlations and sampling times between the waves is illustrated in Figure 2, where increasing sampling time confers a lower correlation between samples for Horvath Δage (Beta=-0.015 units per year, p-value = 9.3 × 10−4), but less so for Hannum Δage (Beta=-0.009 units per year, p-value = .039). Sensitivity analyses keeping only individuals with three measures confirmed the decreasing correlation pattern for Horvath Δage (Beta=-0.016 units per year, p-value = 2.5 × 10−4) but not for Hannum Δage (Beta = −0.005 units per year, p-value = .28).
Table 2.

Pearson Correlations of Epigenetic Δage Between Waves in Each Cohort

Figure 2.

Within-cohort correlations of epigenetic Δage across study waves. For each data set, correlations between all possible combinations of waves were calculated and plotted. On the x-axis is the time between the two measurements in years and on the y-axis is the correlation coefficient.

Pearson Correlations of Epigenetic Δage Between Waves in Each Cohort Within-cohort correlations of epigenetic Δage across study waves. For each data set, correlations between all possible combinations of waves were calculated and plotted. On the x-axis is the time between the two measurements in years and on the y-axis is the correlation coefficient.

Discussion

In this article, we presented the first comprehensive analysis of the epigenetic clock from a longitudinal perspective by analysing data from five prospective cohorts with repeated sampling. We showed that epigenetic age was highly correlated with chronologic age when including multiple samples per individual, and that Δage declined over the life span. Moreover, cross-correlations of Δage from different waves indicated more similar patterns in samples collected closer in time compared to samples collected further apart, although the pattern was more prominent in Horvath than in Hannum estimates. The epigenetic clock has been shown to be a useful marker of biological age when using data from cross-sectional sample collections (19). Here, we provided evidence for its usefulness in a longitudinal perspective. The overall correlations with chronologic age were high, as judged from the individual trajectory plots, and thus comparable to cross-sectional study findings. However, the trajectories of Δage showed a declining trend in almost all of the cohorts with adult sample collections. This indicates that epigenetic age increases at a slower rate than chronological age, especially in the oldest population. Some of the effect is likely driven by survival bias, where healthy individuals are those maintained within a longitudinal study, although other factors like underlying training population for the respective clocks may also have influenced this trend. It may also be possible that there is a ceiling effect for Δage whereby epigenetic clock estimates plateau. In children, the Horvath epigenetic age declined with chronologic age, although less so than in the adult life span, while the Hannum clock was not trained in children and hence was not used. The investigation of correlations between different waves in each cohort showed a decreasing correlation for samples collected further apart, which is in line with expectations where measures further apart have been more influenced by other (environmental) factors. However, it should be noted that the trend is somewhat different for Horvath and Hannum clocks. This is perhaps not surprising given that they represent different tissues; Horvath is a multi-tissue clock built to capture more variation while Hannum only applies to blood leukocytes (only a few CpG sites overlap in the two clocks) and all our samples came from blood leukocytes. The strength of this study is the joint effort of combining five longitudinal cohorts, comprising six data sets, with repeated sample collections assessed by DNA methylation 450k arrays. By doing so, we were able to capture the full life-course perspective of the epigenetic clock from childhood to old age. However, there is an overrepresentation of samples collected at the later part of the life span, which limits the interpretations. Moreover, these cohorts are all based on individuals from a European ancestry background. As there is evidence for differences based on the epigenetic clock in other ethnic populations (20), our findings are not necessarily generalizable to other ethnicities. In summary, we have provided an analysis of longitudinal trajectories of the epigenetic clock across the life course, showing that epigenetic age increases at a slower rate than chronological age across the life course, especially in the oldest population.

Funding

The UK Medical Research Council and Wellcome (grant number 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Matthew Suderman will serve as guarantor for the ALSPAC-related contents of this article. Analysis of the ALSPAC data was funded by UK Economic and Social Research Council grant (grant number ES/N000498/1). ARIES was funded by the BBSRC (BBI025751/1 and BB/I025263/1). Supplementary funding to generate DNA methylation data which are (or will be) included in ARIES has been obtained from the MRC, ESRC, NIH, and other sources. ARIES is maintained under the auspices of the MRC Integrative Epidemiology Unit at the University of Bristol (grant numbers MC_UU_12013/2, MC_UU_12013/8 and MC_UU_12013/9). The InCHIANTI study baseline (1998–2000) was supported as a “targeted project” (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336). The SATSA study was supported by NIH grants R01 AG04563, AG10175, AG028555, the MacArthur Foundation Research Network on Successful Aging, the Swedish Council for Working Life and Social Research (FAS/FORTE) (97:0147:1B, 2009-0795, 2013–2292), the Swedish Research Council (825-2007-7460, 825-2009-6141, 521-2013-8689, 2015–03255), KI Foundation, the Strategic Research Program in Epidemiology at Karolinska Institutet, and by Erik Rönnbergs donation for scientific studies in aging and age-related diseases. R.E.M. and I.J.D. conducted the research in The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the cross-council Lifelong Health and Wellbeing Initiative (MR/K026992/1); funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged. Phenotype collection in the Lothian Birth Cohort 1921 was supported by the UK’s Biotechnology and Biological Sciences Research Council (BBSRC), The Royal Society and The Chief Scientist Office of the Scottish Government. Phenotype collection in the Lothian Birth Cohort 1936 was supported by Age UK (The Disconnected Mind project). Methylation typing was supported by Centre for Cognitive Ageing and Cognitive Epidemiology (Pilot Fund award), Age UK, The Wellcome Trust Institutional Strategic Support Fund, The University of Edinburgh, and The University of Queensland.

Conflict of interest statement

None declared. Click here for additional data file.
  19 in total

1.  Evaluation of the Infinium Methylation 450K technology.

Authors:  Sarah Dedeurwaerder; Matthieu Defrance; Emilie Calonne; Hélène Denis; Christos Sotiriou; François Fuks
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

2.  The Swedish Adoption Twin Study of Aging: an update.

Authors:  N L Pedersen; G E McClearn; R Plomin; J R Nesselroade; S Berg; U DeFaire
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1991

3.  Data Resource Profile: Accessible Resource for Integrated Epigenomic Studies (ARIES).

Authors:  Caroline L Relton; Tom Gaunt; Wendy McArdle; Karen Ho; Aparna Duggirala; Hashem Shihab; Geoff Woodward; Oliver Lyttleton; David M Evans; Wolf Reik; Yu-Lee Paul; Gabriella Ficz; Susan E Ozanne; Anil Wipat; Keith Flanagan; Allyson Lister; Bastiaan T Heijmans; Susan M Ring; George Davey Smith
Journal:  Int J Epidemiol       Date:  2015-05-19       Impact factor: 7.196

4.  Cohort profile: the Lothian Birth Cohorts of 1921 and 1936.

Authors:  Ian J Deary; Alan J Gow; Alison Pattie; John M Starr
Journal:  Int J Epidemiol       Date:  2011-12-14       Impact factor: 7.196

5.  Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort.

Authors:  Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Andy Boyd; Jean Golding; George Davey Smith; John Henderson; John Macleod; Lynn Molloy; Andy Ness; Susan Ring; Scott M Nelson; Debbie A Lawlor
Journal:  Int J Epidemiol       Date:  2012-04-16       Impact factor: 7.196

6.  Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children.

Authors:  Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-04-16       Impact factor: 7.196

7.  DNA methylation-based measures of biological age: meta-analysis predicting time to death.

Authors:  Brian H Chen; Riccardo E Marioni; Elena Colicino; Marjolein J Peters; Cavin K Ward-Caviness; Pei-Chien Tsai; Nicholas S Roetker; Allan C Just; Ellen W Demerath; Weihua Guan; Jan Bressler; Myriam Fornage; Stephanie Studenski; Amy R Vandiver; Ann Zenobia Moore; Toshiko Tanaka; Douglas P Kiel; Liming Liang; Pantel Vokonas; Joel Schwartz; Kathryn L Lunetta; Joanne M Murabito; Stefania Bandinelli; Dena G Hernandez; David Melzer; Michael Nalls; Luke C Pilling; Timothy R Price; Andrew B Singleton; Christian Gieger; Rolf Holle; Anja Kretschmer; Florian Kronenberg; Sonja Kunze; Jakob Linseisen; Christine Meisinger; Wolfgang Rathmann; Melanie Waldenberger; Peter M Visscher; Sonia Shah; Naomi R Wray; Allan F McRae; Oscar H Franco; Albert Hofman; André G Uitterlinden; Devin Absher; Themistocles Assimes; Morgan E Levine; Ake T Lu; Philip S Tsao; Lifang Hou; JoAnn E Manson; Cara L Carty; Andrea Z LaCroix; Alexander P Reiner; Tim D Spector; Andrew P Feinberg; Daniel Levy; Andrea Baccarelli; Joyce van Meurs; Jordana T Bell; Annette Peters; Ian J Deary; James S Pankow; Luigi Ferrucci; Steve Horvath
Journal:  Aging (Albany NY)       Date:  2016-09-28       Impact factor: 5.682

8.  DNA methylation arrays as surrogate measures of cell mixture distribution.

Authors:  Eugene Andres Houseman; William P Accomando; Devin C Koestler; Brock C Christensen; Carmen J Marsit; Heather H Nelson; John K Wiencke; Karl T Kelsey
Journal:  BMC Bioinformatics       Date:  2012-05-08       Impact factor: 3.169

Review 9.  The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond.

Authors:  Ian J Deary; Alan J Gow; Michelle D Taylor; Janie Corley; Caroline Brett; Valerie Wilson; Harry Campbell; Lawrence J Whalley; Peter M Visscher; David J Porteous; John M Starr
Journal:  BMC Geriatr       Date:  2007-12-05       Impact factor: 3.921

10.  Genetic and environmental exposures constrain epigenetic drift over the human life course.

Authors:  Sonia Shah; Allan F McRae; Riccardo E Marioni; Sarah E Harris; Jude Gibson; Anjali K Henders; Paul Redmond; Simon R Cox; Alison Pattie; Janie Corley; Lee Murphy; Nicholas G Martin; Grant W Montgomery; John M Starr; Naomi R Wray; Ian J Deary; Peter M Visscher
Journal:  Genome Res       Date:  2014-09-23       Impact factor: 9.043

View more
  25 in total

1.  Human epigenetic ageing is logarithmic with time across the entire lifespan.

Authors:  Sagi Snir; Colin Farrell; Matteo Pellegrini
Journal:  Epigenetics       Date:  2019-06-06       Impact factor: 4.528

2.  Epigenome wide comparison of DNA methylation profile between paired umbilical cord blood and neonatal blood on Guthrie cards.

Authors:  Yu Jiang; Jinfeng Wei; Hongmei Zhang; Susan Ewart; Faisal I Rezwan; John W Holloway; Hasan Arshad; Wilfried Karmaus
Journal:  Epigenetics       Date:  2019-12-09       Impact factor: 4.528

3.  Decline in biological resilience as key manifestation of aging: Potential mechanisms and role in health and longevity.

Authors:  Svetlana Ukraintseva; Konstantin Arbeev; Matt Duan; Igor Akushevich; Alexander Kulminski; Eric Stallard; Anatoliy Yashin
Journal:  Mech Ageing Dev       Date:  2020-12-16       Impact factor: 5.432

4.  Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging.

Authors:  Hunter L Porter; Chase A Brown; Xiavan Roopnarinesingh; Cory B Giles; Constantin Georgescu; Willard M Freeman; Jonathan D Wren
Journal:  Aging Cell       Date:  2021-10-16       Impact factor: 9.304

5.  Effects of Vitamin D3 Supplementation on Epigenetic Aging in Overweight and Obese African Americans With Suboptimal Vitamin D Status: A Randomized Clinical Trial.

Authors:  Li Chen; Yanbin Dong; Jigar Bhagatwala; Anas Raed; Ying Huang; Haidong Zhu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

6.  Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial.

Authors:  Anat Yaskolka Meir; Maria Keller; Stephan H Bernhart; Ehud Rinott; Gal Tsaban; Hila Zelicha; Alon Kaplan; Dan Schwarzfuchs; Ilan Shelef; Yftach Gepner; Jun Li; Yifei Lin; Matthias Blüher; Uta Ceglarek; Michael Stumvoll; Peter F Stadler; Meir J Stampfer; Peter Kovacs; Liming Liang; Iris Shai
Journal:  Clin Epigenetics       Date:  2021-03-04       Impact factor: 6.551

7.  Accelerated DNA methylation age and the use of antihypertensive medication among older adults.

Authors:  Xu Gao; Elena Colicino; Jincheng Shen; Allan C Just; Jamaji C Nwanaji-Enwerem; Cuicui Wang; Brent Coull; Xihong Lin; Pantel Vokonas; Yinan Zheng; Lifang Hou; Joel Schwartz; Andrea A Baccarelli
Journal:  Aging (Albany NY)       Date:  2018-11-10       Impact factor: 5.682

8.  Developmental Tuning of Epigenetic Clock.

Authors:  Alexander Vaiserman
Journal:  Front Genet       Date:  2018-11-22       Impact factor: 4.599

9.  Leisure-time physical activity and DNA methylation age-a twin study.

Authors:  Elina Sillanpää; Miina Ollikainen; Jaakko Kaprio; Xiaoling Wang; Tuija Leskinen; Urho M Kujala; Timo Törmäkangas
Journal:  Clin Epigenetics       Date:  2019-01-19       Impact factor: 6.551

10.  Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging.

Authors:  Daniel L McCartney; Josine L Min; Rebecca C Richmond; Ake T Lu; Maria K Sobczyk; Gail Davies; Linda Broer; Xiuqing Guo; Ayoung Jeong; Jeesun Jung; Silva Kasela; Seyma Katrinli; Pei-Lun Kuo; Pamela R Matias-Garcia; Pashupati P Mishra; Marianne Nygaard; Teemu Palviainen; Amit Patki; Laura M Raffield; Scott M Ratliff; Tom G Richardson; Oliver Robinson; Mette Soerensen; Dianjianyi Sun; Pei-Chien Tsai; Matthijs D van der Zee; Rosie M Walker; Xiaochuan Wang; Yunzhang Wang; Rui Xia; Zongli Xu; Jie Yao; Wei Zhao; Steve Horvath; Riccardo E Marioni; Adolfo Correa; Eric Boerwinkle; Pierre-Antoine Dugué; Peter Durda; Hannah R Elliott; Christian Gieger; Eco J C de Geus; Sarah E Harris; Gibran Hemani; Medea Imboden; Mika Kähönen; Sharon L R Kardia; Jacob K Kresovich; Shengxu Li; Kathryn L Lunetta; Massimo Mangino; Dan Mason; Andrew M McIntosh; Jonas Mengel-From; Ann Zenobia Moore; Joanne M Murabito; Miina Ollikainen; James S Pankow; Nancy L Pedersen; Annette Peters; Silvia Polidoro; David J Porteous; Olli Raitakari; Stephen S Rich; Dale P Sandler; Elina Sillanpää; Alicia K Smith; Melissa C Southey; Konstantin Strauch; Hemant Tiwari; Toshiko Tanaka; Therese Tillin; Andre G Uitterlinden; David J Van Den Berg; Jenny van Dongen; James G Wilson; John Wright; Idil Yet; Donna Arnett; Stefania Bandinelli; Jordana T Bell; Alexandra M Binder; Dorret I Boomsma; Wei Chen; Kaare Christensen; Karen N Conneely; Paul Elliott; Luigi Ferrucci; Myriam Fornage; Sara Hägg; Caroline Hayward; Marguerite Irvin; Jaakko Kaprio; Deborah A Lawlor; Terho Lehtimäki; Falk W Lohoff; Lili Milani; Roger L Milne; Nicole Probst-Hensch; Alex P Reiner; Beate Ritz; Jerome I Rotter; Jennifer A Smith; Jack A Taylor; Joyce B J van Meurs; Paolo Vineis; Melanie Waldenberger; Ian J Deary; Caroline L Relton
Journal:  Genome Biol       Date:  2021-06-29       Impact factor: 17.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.